HK2 catalyzes the first committed step of glucose metabolism and initiates the major pathways of glucose utilization, it is confirmed to be a tumor promoter and plays an important regulating role in glucose metabolism in multiple malignancies, including breast cancer, lung cancer, and liver cancers (Kawai et al., 2005; Zhang et al., 2020a). The gene discussed is HK2; the disease is neoplasm.